Varex Imaging Co. (NASDAQ:VREX) Shares Sold by Mackenzie Financial Corp

Mackenzie Financial Corp cut its position in Varex Imaging Co. (NASDAQ:VREXFree Report) by 15.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 10,381 shares of the company’s stock after selling 1,854 shares during the quarter. Mackenzie Financial Corp’s holdings in Varex Imaging were worth $213,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in VREX. Federated Hermes Inc. increased its stake in Varex Imaging by 216.3% in the third quarter. Federated Hermes Inc. now owns 1,781 shares of the company’s stock valued at $33,000 after purchasing an additional 1,218 shares during the period. Factorial Partners LLC purchased a new position in shares of Varex Imaging during the third quarter worth about $242,000. Fox Run Management L.L.C. acquired a new position in Varex Imaging in the 3rd quarter valued at about $247,000. Versor Investments LP acquired a new stake in Varex Imaging during the 3rd quarter worth approximately $270,000. Finally, Teza Capital Management LLC acquired a new stake in Varex Imaging during the 3rd quarter worth approximately $332,000.

Varex Imaging Stock Up 0.7 %

VREX stock opened at $16.91 on Tuesday. The stock has a market capitalization of $686.55 million, a PE ratio of 17.61, a price-to-earnings-growth ratio of 2.42 and a beta of 0.69. The company has a fifty day moving average of $17.39 and a 200-day moving average of $18.56. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.37 and a current ratio of 4.30. Varex Imaging Co. has a one year low of $16.62 and a one year high of $23.90.

Varex Imaging (NASDAQ:VREXGet Free Report) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $0.06 EPS for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.05). Varex Imaging had a net margin of 5.08% and a return on equity of 9.21%. The firm had revenue of $190.00 million during the quarter, compared to analyst estimates of $187.97 million. During the same quarter in the previous year, the business earned $0.08 EPS. Varex Imaging’s revenue for the quarter was down 7.6% on a year-over-year basis. As a group, analysts expect that Varex Imaging Co. will post 0.99 EPS for the current year.

Analyst Ratings Changes

Separately, TheStreet cut Varex Imaging from a “b-” rating to a “c” rating in a research note on Tuesday, February 6th.

Read Our Latest Stock Analysis on VREX

About Varex Imaging

(Free Report)

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

Featured Stories

Want to see what other hedge funds are holding VREX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varex Imaging Co. (NASDAQ:VREXFree Report).

Institutional Ownership by Quarter for Varex Imaging (NASDAQ:VREX)

Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.